| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1528 nt | 0.5524 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1219 nt | 0.5291 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1240 nt | 0.5306 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1077 nt | 0.5330 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1330 nt | 0.5331 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1351 nt | 0.5344 | |
| GGGAACUACUCGACCCACAGAGCCGAUCGCGGAGCGGAUUCUGCUUUUA… | 1417 nt | 0.5505 |
This gene encodes an enzyme that catalyzes the production of geranyl pyrophosphate and farnesyl pyrophosphate from isopentenyl pyrophosphate and dimethylallyl pyrophosphate. The resulting product, farnesyl pyrophosphate, is a key intermediate in cholesterol and sterol biosynthesis, a substrate for protein farnesylation and geranylgeranylation, and a ligand or agonist for certain hormone receptors and growth receptors. Drugs that inhibit this enzyme prevent the post-translational modifications of small GTPases and have been used to treat diseases related to bone resorption. Multiple pseudogenes have been found on chromosomes 1, 7, 14, 15, 21 and X. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2008]
A study in rats demonstrated that farnesyl diphosphate synthase (FDPS) was significantly increased in expression in liver tissue on day 1 following a 20% total body surface area burn injury, as part of a comprehensive gene expression profiling analysis [Jayaraman et al. DOI:10.1016/j.jss.2007.05.025]. This upregulation was functionally classified within metabolism, specifically cholesterol synthesis, and was part of the hepatic response where over 60% of differentially expressed genes showed significant changes on day 1 or day 7 post-injury.